Cancer Treatment News and Research

RSS

Phone-based palliative care support program helps alleviate caregiver depression, burden

The earlier a specific phone-based, palliative care support program can be introduced to caregivers, the better they will be able to cope with the caregiving experience, according to research conducted by University of Alabama at Birmingham School of Nursing investigators.

4 Jun 2014

Enzalutamide drug proves effective in stemming progression of prostate cancer

A drug used to treat men with late-stage prostate cancer proved effective in stemming progression of the disease in research participants who had not yet received chemotherapy and extended their survival, according to results from a multi-national Phase III clinical trial led by the Knight Cancer Institute at Oregon Health & Science University.

3 Jun 2014

Ovarian cancer patients with molecular subtypes benefit from bevacizumab

Molecular sequencing could identify ovarian cancer patients who are most likely to benefit from treatment with bevacizumab (Avastin), a Mayo Clinic-led study has found.

2 Jun 2014

Ezyme used as target for antidepressants may also provide way to cure prostate cancer

An international team of scientists including researchers at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute and the University of Southern California found that an enzyme commonly used as a target for antidepressants may also promote prostate cancer growth.

2 Jun 2014

Memorial Sloan Kettering Cancer Center, Quest Diagnostics partner for cancer tests

Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, and Quest Diagnostics, the world's leading provider of diagnostic information services, today announced a joint collaboration that will utilize MSK's clinical and research insights into gene mutations associated with solid tumors.

From Quest Diagnostics 2 Jun 2014

Investigational drug for advanced bladder cancer shows promise for treatment of certain tumor types

A multi-center phase I study using an investigational drug for advanced bladder cancer patients who did not respond to other treatments has shown promising results in patients with certain tumor types, researchers report.

31 May 2014

HCV reactivation may not worsen survival outcomes for lymphoma patients with HIV

More than a quarter of HIV+ patients are also infected with the Hepatitis C virus (HCV), which may complicate treatment and care decisions after a cancer diagnosis. The specifics of those complications haven't been well-researched in the past. Results from a new Fox Chase Cancer Center study on this patient population may start filling in that gap.

31 May 2014

ASCO Expert Panel develops treatment guidelines for cancer-related fatigue

Fatigue is a debilitating problem for cancer patients undergoing treatment; however, it also poses a huge detriment after treatment and can significantly affect quality of life.

31 May 2014

Research roundup: End-of-life preferences; surviving trauma when older; ACA's big waiver for states

Policies and practices that promote advance care planning and advance directive completion implicitly assume that patients' choices for end-of-life (EOL) care are stable over time, even with changes in health status.

31 May 2014

Patients with AIDS-related lymphomas may face increased risk of CNSi

Patients with AIDS-related lymphomas (ARL) may face an increased risk of central nervous system involvement (CNSi) compared to other lymphomas. The effect of CNSi on survival outcomes, however, hasn't been thoroughly examined until now.

31 May 2014

Type of surgeon has influence on long-term outcomes for rectal cancer surgery patients

A new Mayo Clinic study shows that the type of surgeon and the type of hospital have a significant influence on long-term outcomes for patients who undergo surgery for rectal cancer.

30 May 2014

ALOXI injection receives FDA approval for prevention of nausea, vomiting associated with cancer chemotherapy

Eisai Inc. and Helsinn Group today announced the Food and Drug Administration (FDA) approval of ALOXI (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy, in children aged 1 month to less than 17 years.

29 May 2014

New program appears to be effective in reducing risk of lymphedema in breast cancer survivors

Viewed as one of the most unfortunate outcomes of breast cancer treatment, lymphedema is characterized by an accumulation of lymph fluid in the interstitial spaces of the affected limb, leading to chronic ipsilateral limb swelling causing psychosocial distress and physical challenges for patients.

29 May 2014

MedPage and CollabRx introduce CancerRx to help oncologists, pathologists

MedPage Today, a property of Everyday Health, Inc. and CollabRx, Inc. announced today the introduction of a new physician resource, CancerRx,™ an IOS application designed to help oncologists and pathologists navigate the complex landscape of oncology therapeutic options.

28 May 2014

Spokane Valley Cancer Center partners with SCCA Network to become 12th Member in Northwest

Spokane Valley Cancer Center joined the Seattle Cancer Care Alliance (SCCA) Network to become its 12th Member in the Northwest this month. This relationship will expand access to cancer treatment options and help foster advances in cancer care in the greater Spokane community.

28 May 2014

Study reveals high demand for costly cancer treatment among refugees from Iraq, Syria

A study published in The Lancet Oncology journal reveals a high demand for costly cancer treatment among refugees from the recent conflicts in Iraq and Syria, with host countries struggling to find the money and the medicine to treat their new patients.

26 May 2014

Researchers identify chemical signals that promote breast cancer metastasis

Working with mice, Johns Hopkins researchers report they have identified chemical signals that certain breast cancers use to recruit two types of normal cells needed for the cancers' spread.

23 May 2014

Researchers explore perceptions of cancer trials on ‘International Clinical Trials Day’

A new article published by ecancermedicalscience on May 20th addresses the question of why cancer patients are afraid of participating in potentially life-saving clinical trials.

21 May 2014

Viewpoints: Cutting costs for patients with chronic illness; Gov. Pence's change of Heart; fix the VA

Most health care plans ask that you spend some money out of your pocket whenever you use the health care system. This is known as cost-sharing .... Cost-sharing works for most people, because most people are healthy. Healthy people who use health care are often doing so inefficiently.

21 May 2014

Nationwide Children's Hospital offers Meta-iodobenzylguanidine therapy for neuroblastoma

Meta-iodobenzylguanidine (MIBG) therapy is now offered by Hematology/Oncology/Blood and Marrow Transplant at Nationwide Children's Hospital. Patients with neuroblastoma who qualify for treatment with MIBG therapy can be treated in this new facility, with round-the-clock supervision by specially trained staff through video and audio monitoring.

21 May 2014

Cancer Treatment News and Research

Phone-based palliative care support program helps alleviate caregiver depression, burden

Enzalutamide drug proves effective in stemming progression of prostate cancer

Ovarian cancer patients with molecular subtypes benefit from bevacizumab

Ezyme used as target for antidepressants may also provide way to cure prostate cancer

Memorial Sloan Kettering Cancer Center, Quest Diagnostics partner for cancer tests

Investigational drug for advanced bladder cancer shows promise for treatment of certain tumor types

HCV reactivation may not worsen survival outcomes for lymphoma patients with HIV

ASCO Expert Panel develops treatment guidelines for cancer-related fatigue

Research roundup: End-of-life preferences; surviving trauma when older; ACA's big waiver for states

Patients with AIDS-related lymphomas may face increased risk of CNSi

Type of surgeon has influence on long-term outcomes for rectal cancer surgery patients

ALOXI injection receives FDA approval for prevention of nausea, vomiting associated with cancer chemotherapy

New program appears to be effective in reducing risk of lymphedema in breast cancer survivors

MedPage and CollabRx introduce CancerRx to help oncologists, pathologists

Spokane Valley Cancer Center partners with SCCA Network to become 12th Member in Northwest

Study reveals high demand for costly cancer treatment among refugees from Iraq, Syria

Researchers identify chemical signals that promote breast cancer metastasis

Researchers explore perceptions of cancer trials on ‘International Clinical Trials Day’

Viewpoints: Cutting costs for patients with chronic illness; Gov. Pence's change of Heart; fix the VA

Nationwide Children's Hospital offers Meta-iodobenzylguanidine therapy for neuroblastoma

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News